FDA inspection
Cooper Health System IRB: FDA inspection ending Dec 4, 2025
FDA inspection 1294644 · Camden, NJ
Key facts
| Inspection ID | 1294644 |
|---|---|
| Firm | Cooper Health System IRB |
| FEI number | 2243630 |
| Address | 401 Haddon Ave |
| City | Camden |
| State | NJ |
| ZIP | 08103-1505 |
| Fiscal year | 2026 |
| Inspection end date | Dec 4, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices |
| Product type | Biologics, Devices, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data